Insider Trading June 5, 2026 05:55 PM

Cleveland-Cliffs Executive Unloads $2.87 Million in Stock Amid Strategic Shifts

CFO Celso L Jr. liquidates 214,308 shares at $13.355-$13.48 per share; company reports Q1 2026 earnings beat and announces AI partnership with Palantir.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
CLF

Celso L Jr., Executive Vice President and Chief Financial Officer of Cleveland-Cliffs Inc. (CLF), executed a sale of 214,308 common shares on June 5, 2026, totaling $2,874,641. The transaction, conducted at prices between $13.355 and $13.48 per share, leaves Mr. Goncalves with a direct holding of 184,541.613 shares. This sale occurs against a backdrop of a 91% stock surge over the past year, though valuation metrics suggest potential overvaluation. Concurrently, Cleveland-Cliffs reported Q1 2026 earnings that exceeded expectations, with an EPS of -$0.40 versus a forecasted -$0.41 and revenue of $4.9 billion compared to $4.81 billion anticipated. The company also announced a three-year AI partnership with Palantir Technologies to enhance manufacturing operations. Shareholders at the annual meeting re-elected directors, including Lourenco Goncalves and Ralph S. Michael III, with strong support, signaling leadership continuity.

Cleveland-Cliffs Executive Unloads $2.87 Million in Stock Amid Strategic Shifts
CLF
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Cleveland-Cliffs CFO Celso L Jr. sold 214,308 shares worth $2.87 million, retaining 184,541.613 shares post-transaction.
  • Q1 2026 financials showed an EPS of -$0.40 beating forecasts of -$0.41, with revenue of $4.9 billion exceeding the $4.81 billion estimate.
  • A three-year partnership with Palantir Technologies was announced to implement AI solutions for manufacturing optimization.

Celso L Jr., serving as Executive Vice President and Chief Financial Officer at CLEVELAND-CLIFFS INC. (CLF), completed a transaction selling 214,308 common shares on June 5, 2026. The aggregate value of this divestment reached $2,874,641. The execution occurred across multiple transactions, with share prices fluctuating between $13.355 and $13.48. Post-transaction, Mr. Goncalves maintains a direct ownership position of 184,541.613 common shares within the enterprise.

This insider activity unfolds following a significant appreciation in Cleveland-Cliffs stock, which has climbed approximately 91% over the trailing twelve months. Despite this momentum, analytical assessments indicate the security may be trading above its intrinsic fair value. Observations note considerable volatility in the stock's price behavior, a factor warranting attention for market participants. Deeper valuation insights and additional analytical tips are available through specialized financial platforms.

In parallel corporate developments, Cleveland-Cliffs disclosed its first quarter of 2026 financial results. The earnings report revealed a narrower-than-anticipated loss, with earnings per share (EPS) recorded at -$0.40, marginally outperforming the consensus forecast of -$0.41. Revenue metrics also surpassed projections, posting $4.9 billion against an expected $4.81 billion. Furthermore, the company formalized a three-year collaboration with Palantir Technologies. This partnership focuses on deploying artificial intelligence solutions throughout its manufacturing operations, aiming to optimize production planning, streamline order entry, and improve operational workflows through real-time data integration and activity coordination.

During its annual shareholder meeting, Cleveland-Cliffs secured re-election for all nominated directors. This group includes Lourenco Goncalves and Ralph S. Michael III, who will serve terms extending to the 2027 annual meeting. The board nominees received substantial backing, with 'for' votes ranging from approximately 323.2 million to 330.2 million. These events underscore the company's emphasis on technological advancement and stable governance.

Risks

  • Analyst notes suggest the stock may be overvalued relative to its fair value, indicating potential correction risks.
  • The article highlights considerable volatility in the stock's price movements, which could impact investor returns.
  • Regulatory and operational integration challenges may arise from the large-scale AI implementation across manufacturing operations.

More from Insider Trading

Rocket Lab Director Slusky Offloads $4.94M in Equity Amid Sector Valuation Debate Jun 5, 2026 Xeris Biopharma Director Marla Persky Executes Strategic Share Transactions Amidst Financial Momentum Jun 5, 2026 Getty Images Executive Offloads Shares Amidst Merger Uncertainty and Earnings Miss Jun 5, 2026 Datadog Director Dev Ittycheria Offloads $34.3 Million in Shares Amid Strong Stock Performance Jun 5, 2026 Xeris Biopharma Director John Johnson Executes Share Transactions Amidst Strong Quarterly Performance Jun 5, 2026